NasdaqCM - Delayed Quote USD

Semler Scientific, Inc. (SMLR)

Compare
59.27 +12.93 (+27.90%)
At close: November 20 at 4:00 PM EST
68.19 +8.92 (+15.05%)
Pre-Market: 4:38 AM EST
Loading Chart for SMLR
DELL
  • Previous Close 46.34
  • Open 49.15
  • Bid 58.76 x 700
  • Ask 59.72 x 300
  • Day's Range 45.35 - 61.55
  • 52 Week Range 20.88 - 61.55
  • Volume 2,487,046
  • Avg. Volume 245,234
  • Market Cap (intraday) 430.67M
  • Beta (5Y Monthly) 0.92
  • PE Ratio (TTM) 29.05
  • EPS (TTM) 2.04
  • Earnings Date Nov 4, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 40.00

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

www.semlerscientific.com

92

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SMLR

View More

Performance Overview: SMLR

Trailing total returns as of 11/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SMLR
33.82%
S&P 500
24.05%

1-Year Return

SMLR
51.39%
S&P 500
31.08%

3-Year Return

SMLR
39.21%
S&P 500
25.95%

5-Year Return

SMLR
37.84%
S&P 500
89.64%

Compare To: SMLR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SMLR

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    430.67M

  • Enterprise Value

    418.09M

  • Trailing P/E

    29.05

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.81

  • Price/Book (mrq)

    5.05

  • Enterprise Value/Revenue

    7.09

  • Enterprise Value/EBITDA

    20.21

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    27.00%

  • Return on Assets (ttm)

    14.60%

  • Return on Equity (ttm)

    20.39%

  • Revenue (ttm)

    58.94M

  • Net Income Avi to Common (ttm)

    15.91M

  • Diluted EPS (ttm)

    2.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.67M

  • Total Debt/Equity (mrq)

    0.11%

  • Levered Free Cash Flow (ttm)

    -56.74M

Research Analysis: SMLR

View More

Company Insights: SMLR

Research Reports: SMLR

View More

People Also Watch